☰ Navigation Tabs
Solution structure of ADF/cofilin (LDCOF) from Leishmania donovani
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-15N HSQC 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 2 2D 1H-13C HSQC aliphatic 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O 100% D2O 50 6.5 ambient 298 3 3D CBCA(CO)NH 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 4 3D HNCACB 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 5 3D HNCO 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 6 3D HN(CA)CO 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 7 3D HCCH-TOCSY 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 8 3D H(CCO)NH 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 9 3D C(CO)NH 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 10 3D 1H-15N NOESY 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 11 3D 1H-13C NOESY aliphatic 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O 100% D2O 50 6.5 ambient 298 12 3D 1H-13C NOESY aromatic 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O 100% D2O 50 6.5 ambient 298 13 2D HB(CBCGCD)HD 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 14 2D HB(CBCGCE)HE 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 95% H2O/5% D2O 95% H2O/5% D2O 50 6.5 ambient 298 15 2D 1H-13C HSQC aromatic 20mM sodium phosphate; 50mM sodium chloride; 0.1% sodium azide; 1mM AEBSF protease inhibitor; 1mM DTT; 100% D2O 100% D2O 50 6.5 ambient 298
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Varian INOVA 600 2 Bruker AVANCE 800
NMR Refinement Method Details Software torsion angle dynamics NMRPipe
NMR Ensemble Information Conformer Selection Criteria target function Conformers Calculated Total Number 200 Conformers Submitted Total Number 10 Representative Model 1 (lowest energy)
Computation: NMR Software # Classification Version Software Name Author 1 processing NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax 2 processing NMRDraw Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax 3 chemical shift assignment CARA 1.8.4 Keller and Wuthrich 4 structure solution TALOS TALOS+ Cornilescu, Delaglio and Bax 5 structure solution CYANA 3.0 Guntert, Mumenthaler and Wuthrich 6 data analysis PSVS 1.4 Bhattacharya and Montelione 7 refinement CYANA 3.0 Guntert, Mumenthaler and Wuthrich 8 refinement TALOS TALOS+ Cornilescu, Delaglio and Bax 9 refinement CING Vuister et al.